The IPO Buzz: Parabilis Therapeutics (PBLS Proposed) Upsizes IPO by 1/3 to $600 Million
Parabilis Therapeutics (PBLS Proposed) upsized its IPO to 33.33 million shares – up from 25 million initially – and keeping the price range at $17.00 to $19.00 - to raise $600 million, if priced at the $18.00 mid-point of its range, according to an S-1/A filing early today – Tuesday, June 9, 2026. The cancer biotech’s IPO is set to price tonight – after the closing bell – to tra..
Read more June 9, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| ERock, Inc. | EROC | 27.9 | $ 600.0 mil | 6/10/2026 Priced | S/O | S/O |
| JAB Acquisition Corp. I | JABU | 15.0 | $ 150.0 mil | 6/10/2026 Priced | S/O | S/O |
| Parabilis Medicines | PBLS | 33.5 | $ 670.0 mil | 6/10/2026 Priced | S/O | S/O |
Last 100 IPOs - June 9, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 53 |
| Number Down: | 45 |
| Number Unchanged: | 2 |
| Percentage Change From Issue Price: | 7.68% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - June 9, 2026
| Number of IPOs priced (Excluding 106 units) : | 79 |
| Number Up: | 42 |
| Number Down: | 35 |
| Number Unchanged: | 2 |
| Total Return From Issue Price: | 6.89% |
| The Nasdaq Composite Index YTD % Change | 35.22% |